The Randomized Blind Start Trial: Evaluation of A New Study Design for Assessing Clinical Outcomes in Rare and Heterogeneous Patient Populations
Value Health
.
2014 Nov;17(7):A580.
doi: 10.1016/j.jval.2014.08.1963.
Epub 2014 Oct 26.
Authors
J Signorovitch
1
,
R Ayyagari
2
,
E Kakkis
3
Affiliations
1
Analysis Group, Inc., Boston, MA, USA.
2
Analysis Group Inc., Boston, MA, USA.
3
Ultragenyx Pharmaceutical Inc., Novato, CA, USA.
PMID:
27201958
DOI:
10.1016/j.jval.2014.08.1963
No abstract available